Personalis, Inc.
MENLO PARK, CA · Founded 2011 · CIK 0001527753 · Medtech · Public
Advanced circulating tumor DNA (ctDNA) detection platform for cancer molecular residual disease monitoring and therapy selection
personalis.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $69M
- 4 Form D · Jul 2017
- 111 months since last filing
- Contracts
- $246M
- 47 awards · Veterans Affairs, Health and Human S
- #3 of 4531 in medtech
- Patents
- 40
- 25 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,006,851 | |
| Federal contract | Department of Veterans Affairs · Genomics Sequencing. | $4,197,570 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Medical- Laboratory Testing | $45,599 | |
| Federal contract· 1 of 2 same day | Department of Veterans Affairs · Genome Sequencing Igf::ot::igf | $8,999,430 | |
| Federal contract· 2 of 2 same day | Department of Veterans Affairs · Igf::ot::igf Genomic Sequencing | $275,490 | |
| Private capital raised | Form D · SEC | $22,077,923 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing Igf::ot::igf | $40,820 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen-derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. The Contractor Shall Furnish A Robust, Scalable, Dynamic, Secure, Innovative Solutions Of Analyzing Samples Obtained During Regular Clinical Care Such As Tissues From Biopsy - Using New Genomic Assay Technology. The Clia Vendor Shall Provide Emerging Technologies To Improve Oncology Care For All Patients Within The Va Healthca | $240,250 | |
| Private capital raised | Form D · SEC | $29,581,947 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Genomic And Genetic Testing | $15,000 | |
| Federal contract· 1 of 3 same day | Department of Veterans Affairs · Igf::ot::igf Genomic And Genetic Testing --- Opty 1 | $3,325 | |
| Federal contract· 2 of 3 same day | Department of Veterans Affairs · Genomic Sequencing Igf::ot::igf | $247,656 | |
| Federal contract· 3 of 3 same day | Department of Veterans Affairs · Igf::ot::igf Genomic And Genetic Testing -- Opty 1 | $8,075 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen-derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. This Task Order Is For Theace Cancerplus Test (test Number 13-0414) 1 Of 4: Tumor Only, With Clinical Report Only Clin 2010 Targeted Genomic Analysis - Lung Cancer Clin 2011 Target Genomic Analysis - Colon Cancer Clin 2012 Targeted Genomic Analyis - Prostate Cancer Clin 2013 Targeted Genomic Analyis - Melanoma Cancer | $30,470 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen Derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. This Modification Incorporates Ace Cancerplus Test Test Number 13-0414 Tumor Only, With Clinical Report Only; The Test Is A 181 Cancer Gene Test, And The Same As Ace Cancerplus Less The Research Data Component In Sow Task 8, Paragraph 2. | $24,650 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen Derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. This Modification Incorporates Ace Cancerplus Test Test Number 13-0414 Tumor Only, With Clinical Report Only; The Test Is A 181 Cancer Gene Test, And The Same As Ace Cancerplus Less The Research Data Component In Sow Task 8, Paragraph 2. | $99,440 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing Igf::ot::igf | $20,145,616 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen Derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. This Modification Incorporates Ace Cancerplus Test Test Number 13-0414 Tumor Only, With Clinical Report Only; The Test Is A 181 Cancer Gene Test, And The Same As Ace Cancerplus Less The Research Data Component In Sow Task 8, Paragraph 2. | $290,710 | |
| Federal contract· 1 of 3 same day | Department of Veterans Affairs · Igf::ot::igf - Other Function: Genomic And Genetic Testing | $4,515 | |
| Federal contract· 2 of 3 same day | Department of Veterans Affairs · Igf::ot::igf - Other Function: Genomic And Genetic Testing | $9,030 | |
| Federal contract· 3 of 3 same day | Department of Veterans Affairs · Igf::ot::igf - Other Function: Genomic And Genetic Testing | $18,060 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen Derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. This Modification Incorporates Ace Cancerplus Test Test Number 13-0414 Tumor Only, With Clinical Report Only; The Test Is A 181 Cancer Gene Test, And The Same As Ace Cancerplus Less The Research Data Component In Sow Task 8, Paragraph 2. | $49,910 | |
| Federal contract· 1 of 2 same day | Department of Veterans Affairs · Igf::ot::igf Genomic And Genetic Testing | $22,575 | |
| Federal contract· 2 of 2 same day | Department of Veterans Affairs · Igf::ot::igf - Other Function: Genomic And Genetic Testing | $4,515 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf P00002 Modify And Supplement Distribution Of Clinical Reports And Clarify File Format Types. P00002. The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen Derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. This Modification Incorporates Ace Cancerplus Test Test Number 13-0414 Tumor Only, With Clinical Report Only; The Test Is A 181 Cancer Gene Test, And The Same As Ace Cancerplus Less The Research Data Component In Sow Task 8, Pa | $149,580 | |
| Private capital raised | Form D · SEC | $12,225,000 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf The Contractor Shall Provide Enhanced Analysis Of Clinical And Specimen Derived Data On All Patients Seen At Va Network Hospitals Who Have A Cancer Diagnosis. This Modification Incorporates Ace Cancerplus Test Test Number 13-0414 Tumor Only, With Clinical Report Only; The Test Is A 181 Cancer Gene Test, And The Same As Ace Cancerplus Less The Research Data Component In Sow Task 8, Paragraph 2. | $224,750 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Genomic Analysis Of Cancer Tumors | $168,830 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing Igf::ot::igf | $36,616,650 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Oncology Testing Services | $1,071,490 | |
| Federal contract· 1 of 2 same day | Department of Veterans Affairs · Igf::ot::igf Oncology Testing Services | $109,560 | |
| Federal contract· 2 of 2 same day | Department of Veterans Affairs · Genomic Sequencing | $36,498,966 | |
| Federal contract | Department of Veterans Affairs · Genomic Testing Services | $335,520 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing | $38,072,544 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing | $30,866,000 | |
| Federal contract | Department of Veterans Affairs · Genomic Sequencing | $9,747,936 | |
| Federal contract | Department of Veterans Affairs · Augmented Exome Sequencing Services | $99,700 | |
| Federal contract | Department of Veterans Affairs · Whole Genome Sequencing | $9,999,600 | |
| Federal contract· 1 of 2 same day | Department of Veterans Affairs · Whole Genome Sequencing | $7,499,520 | |
| Federal contract· 2 of 2 same day | Department of Veterans Affairs · Whole Genome Sequencing | $230,580 | |
| Federal contract | Department of Veterans Affairs · Whole Genome Sequencing | $7,499,947 | |
| Federal contract | Department of Veterans Affairs · Whole Genome Sequencing | $334,000 | |
| Federal contract | Department of Veterans Affairs · Whole Genome Sequencing | $13,500,000 | |
| Federal contract | Department of Veterans Affairs · EO 14398 | $18,290,000 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1 | SIGNAL SOLUTIONS, LLC | $678M | — |
| 2 | OCEANIT LABORATORIES INC | $250M | — |
| 3 | Personalis, Inc. | $246M | $69M |
| 4 | LYNNTECH INC. | $226M | — |
| 5 | CEPHEID | $219M | $5.2M |
| 6 | Spectral Md, Inc. | $189M | $1.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Patrick BalthropDirector
- Andrew ChungDirector
- Jon FeiberDirector
- Ken LudlumDirector
- Jonathan MacQuittyDirector
- Vincent MilesDirector
- Chris SchaepeDirector
- Sue SiegelDirector
- Carol TillisExecutive Officer
- John WestDirector · Executive Officer
Patents
- Methods And Systems For Genetic Analysisapplication
- System And Method For Management Of Compressed Sequencing Filesgranted
- Methods And Systems For Genetic Analysisapplication
- Methods And Systems For Genetic Analysisgranted
- Methods For Using Mosaicism In Nucleic Acids Sampled Distal To Their Originapplication
- Estimating Tumor Purity From Single Samplesapplication
- Methods And Systems For Genetic Analysisgranted
- Methods For Using Mosaicism In Nucleic Acids Sampled Distal To Their Origingranted
- System And Method For Management Of Compressed Sequencing Filesapplication
- Estimating Tumor Purity From Single Samplesgranted
- Methods And System For Using Methylation Data For Disease Detection And Quantificationapplication
- Customized Assays For Personalized Cancer Monitoringapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.